#AT527

Victoria Yan

victoriacyanide

First-in-Woman Safety, Tolerability, and Pharmacokinetics of Orally Administered #GS441524: A Broad-Spectrum Antiviral Treatment for #COVID19. A 1/7https://osf.io/am5s8/ Part 1 of the study: 750 mg GS-441524 was orally administered as